Protalix BioTherapeutics
PLX
#8577
Rank
A$0.18 B
Marketcap
$2.55
Share price
-1.78%
Change (1 day)
18.48%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$96.59 Million

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are A$96.59 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$74.65 M-23.52%
2022-12-31A$97.61 M-11.21%
2021-12-31A$0.10 B-10.99%
2020-12-31A$0.12 B-25.27%
2019-12-31A$0.16 B2.12%
2018-12-31A$0.16 B24.27%
2017-12-31A$0.13 B1.81%
2016-12-31A$0.12 B7.88%
2015-12-31A$0.11 B-27.56%
2014-12-31A$0.16 B4.08%
2013-12-31A$0.15 B99.1%
2012-12-31A$78.98 M3.99%
2011-12-31A$75.95 M1.45%
2010-12-31A$74.87 M-18.76%
2009-12-31A$92.15 M905.88%
2008-12-31A$9.16 M79.92%
2007-12-31A$5.09 M48.45%
2006-12-31A$3.43 M122.11%
2005-12-31A$1.54 M1583.23%
2004-12-31A$0.09 M-13.48%
2003-12-31A$0.1 M-24.44%
2002-12-31A$0.14 M-7.31%
2001-12-31A$0.15 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.93 B 865.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.25 B 1,196.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$194.72 B 201,488.34%๐Ÿ‡บ๐Ÿ‡ธ USA
A$54.27 B 56,085.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel